Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineReferences
- Quinolone antibiotics induce shiga toxin-encoding bacteriophages, toxin production, and death in mice.J Infect Dis. 2000; 181: 664-670
- Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.Clin Infect Dis. 2012; 55: 33-41
- Infectious Diseases Society of America. Practice guidelines for the management of infectious diarrhea.Clin Infect Dis. 2001; 32: 331-351
- Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline - second edition. CLSI document M45-A2.Clinical and Laboratory Standards Institute, Wayne (PA)2010
- Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. M100 S24.Clinical and Laboratory Standards Institute, Wayne (PA)2014
- Clinical practice. Bacterial diarrhea.N Engl J Med. 2009; 361: 1560-1569
- Incidence and trends of infection with pathogens transmitted commonly through food – foodborne diseases active surveillance network, 10 U.S. sites, 1996-2012.MMWR. 2013; 62: 283-287
- A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species.Clin Infect Dis. 2007; 44: 696-700
- The Sanford guide to antimicrobial therapy.44th edition. Antimicrobial Therapy, Inc, Sperryville (VA)2014
- National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report. U.S. Department of Health and Human Services, CDC, Atlanta (GA)2012 (Available at:) (Accessed March 17, 2015)
- Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni/Campylobacter coli isolates recovered from international travelers, 1994 to 2006.J Travel Med. 2008; 15: 419-425
- Transmission of antibiotic resistance from food animals to humans.in: Nachamkin I. Szymanski C.M. Blaser M.J. Campylobacter. ASM Press, Washington, DC2008: 645-665
- Antimicrobial susceptibility and mechanism of quinolone resistance in Campylobacter jejuni strains isolated from diarrheal patients in a hospital in Tokyo.J Infect Chemother. 2008; 14: 342-348
- Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.Emerg Infect Dis. 2001; 7: 24-34
- Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story.Clin Infect Dis. 2007; 44: 977-980
- Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment.Antimicrob Agents Chemother. 2005; 49: 699-707
- Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure.Proc Natl Acad Sci U S A. 2005; 102: 541-546
- Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections.Int J Antimicrob Agents. 2007; 30: 195-201
- Development of a standardized susceptibility test for Campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem.Microb Drug Resist. 2004; 10: 124-131
- Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; Approved standard - third edition. CLSI document M31-A3.Clinical and Laboratory Standards Institute, Wayne (PA)2008
International Organization for Standardization (ISO) Standards. Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases (ISO 20776–1). Switzerland: ISO; 2006.
- Disk diffusion method for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni and Campylobacter coli.J Clin Microbiol. 2013; 51: 380
- Inaccuracy of the disk diffusion method compared with the agar dilution method for susceptibility testing of Campylobacter spp.J Clin Microbiol. 2012; 50: 52-56
European Committee on Antimicrobial Susceptibility Testing - EUCAST. Breakpoint tables for interpretation of MICs and zone diameters, Version 4.0. 2014. Available at: http://www.eucast.org/clinical_breakpoints/. Accessed March 17, 2015.
CLSI. Subcommittee of the Antimicrobial Susceptibility Testing, June 2014 meeting minutes. Available at: http://clsi.org/standards/micro/microbiology-files/. Accessed March 16, 2015.
- Cost analysis and antimicrobial susceptibility testing comparing the E test and the agar dilution method in Campylobacter jejuni and Campylobacter coli.Diagn Microbiol Infect Dis. 2009; 65: 168-174
- Inaccuracy of routine susceptibility tests for detection of erythromycin resistance of Campylobacter jejuni and Campylobacter coli.Clin Microbiol Infect. 2010; 16: 51-56
- New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria.Clin Infect Dis. 2007; 44: 280-286
- Detection of Campylobacter in stool and determination of significance by culture, enzyme immunoassay, and PCR in developing countries.J Clin Microbiol. 2014; 52: 1074-1080
- Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group.Ann Intern Med. 1992; 117: 202-208
- Shigella infections.in: Pickering L.K. Baker C.J. Kimberlin D.W. Red book: 2012 report of the Committee on Infectious Diseases. 29th edition. American Academy of Pediatrics, Elk Grove Village (IL)2012: 645-647
- The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia.Am J Med. 2001; 110: 60-63
- Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium.J Infect Dis. 2004; 190: 1652-1654
- Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center.N Engl J Med. 1957; 256: 1128-1134
- CTX-M-producing non-Typhi Salmonella spp. isolated from humans, United States.Emerg Infect Dis. 2011; 17: 97-99
- Multidrug-resistant Salmonella typhi: a worldwide epidemic.Clin Infect Dis. 1997; 24: S106-S109
- In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards.Clin Infect Dis. 2012; 55: 1107-1113
- Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance.Antimicrob Agents Chemother. 1999; 43: 1441-1444
- Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents.Clin Infect Dis. 2004; 38: 951-957
- Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin.J Clin Microbiol. 2014; 52: 877-884
- Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. M100 S25.Clinical and Laboratory Standards Institute, Wayne (PA)2015
- Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.Nat Med. 2006; 12: 83-88
- Performance of Etest and disk diffusion for the detection of ciprofloxacin and levofloxacin resistance in Salmonella.J Clin Microbiol. 2015; 53: 298-301
- Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India.J Antimicrob Chemother. 1999; 44: 243-250
- Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?.J Antimicrob Chemother. 2014; 69: 287-291
- Antibiotic therapy for Shigella dysentery.Cochrane Database Syst Rev. 2010; (CD006784)
- Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo.J Pediatr. 1967; 70: 970-981
- Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children.Pediatr Infect Dis J. 2003; 22: 374-377
- Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility.Pediatr Infect Dis J. 2005; 24: 494-497
- Reduced azithromycin susceptibility in Shigella sonnei, United States.Microb Drug Resist. 2010; 16: 245-248
- Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States.Antimicrob Agents Chemother. 2013; 57: 1559-1560
- Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012-2013.Emerg Infect Dis. 2014; 20: 854-856
- Notes from the field: Shigella with decreased susceptibility to azithromycin among men who have sex with men - United States, 2002-2013.MMWR. 2014; 63: 132-133
- Third-generation cephalosporin-resistant Vibrio cholerae, India.Emerg Infect Dis. 2012; 18: 1326-1328
- Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. Cholera outbreak in South Africa, 2008-2009: laboratory analysis of Vibrio cholerae O1 strains.J Infect Dis. 2013; 208: S39-S45
- Single-dose azithromycin for the treatment of cholera in adults.N Engl J Med. 2006; 354: 2452-2462
- Drug-resistance mechanisms in Vibrio cholerae O1 outbreak strain, Haiti, 2010.Emerg Infect Dis. 2011; 17: 2151-2154
Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline - third edition. CLSI document M45–A3. Wayne (PA): Clinical and Laboratory Standards Institute, in press.
- Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.Lancet Infect Dis. 2011; 11: 355-362
- The Aeromonas metallo-beta-lactamases: genetics, enzymology, and contribution to drug resistance.Microb Drug Resist. 1996; 2: 245-252
- Distribution and phenotypic and genotypic detection of a metallo-β-lactamase, CphA, among bacteraemic Aeromonas isolates.J Med Microbiol. 2012; 61: 712-719
- In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).Int J Antimicrob Agents. 2012; 40: S11-S17
- Antibiotic susceptibility profile of Aeromonas species isolated from wastewater treatment plant.ScientificWorldJournal. 2012; 2012: 764563
- Antimicrobial susceptibilities of Clostridium difficile isolated in Japan.J Infect Chemother. 2013; 19: 360-362
- Metronidazole resistance in Clostridium difficile is heterogeneous.J Clin Microbiol. 2008; 46: 3028-3032
- In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin.J Antimicrob Chemother. 2013; 69: 41-44
- Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.Antimicrob Agents Chemother. 2008; 52: 3180-3187
- Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document M100–S23.Clinical and Laboratory Standards Institute, Wayne (PA)2013
- Plesiomonas shigelloides infection in Southeast China.PLoS One. 2013; 8: e77877
- Yersinia enterocolitica infection in diarrheal patients.Eur J Clin Microbiol Infect Dis. 2008; 27: 741-752
Article info
Publication history
Footnotes
The authors have no disclosures to provide.